Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program

被引:0
|
作者
Loke, Ching Ting [1 ,2 ,3 ]
Gaskell, Charlotte [4 ]
Fox, Sonia [4 ]
Fletcher, Rachel [4 ]
Thomas, Catherine [4 ]
Hopkins, Louise [4 ]
Kumari, Anita [4 ]
Boucher, Rebecca H. [4 ]
Nunnick, Jane [1 ,2 ]
Knapper, Steve [5 ]
Toth, Arpad [6 ]
Byrne, Jennifer [7 ]
O'Nions, Jenny [8 ]
Khan, Anjum [9 ]
Zhao, Rui [10 ]
Pillai, Arvind [11 ]
Tholouli, Eleni [12 ]
Dungarwalla, Moez [13 ]
Randall, Katie [14 ]
Dillon, Richard [15 ,16 ]
Murray, Duncan [17 ]
Culligan, Dominic [18 ]
McMullin, Mary Frances [19 ]
Chan, Yuen Ling Tracey [20 ]
Drew, Victoria [21 ]
Murthy, Vidhya [1 ]
Krishnamurthy, Pramila [22 ]
Neelakantan, Pratap [23 ]
Rider, Tom [24 ]
Wandroo, Farooq A. [25 ]
Rafferty, Mark [26 ]
Huang, Ya-Wen [27 ]
Moore, Sally [28 ]
Mehta, Priyanka [29 ]
Partridge, David G. [30 ,31 ]
Craddock, Charles [1 ,2 ]
Lowe, David [32 ,33 ]
Stanworth, Simon J. [34 ,35 ,36 ]
机构
[1] Univ Hosp Birmingham, Ctr Clin Haematol, Birmingham, England
[2] Univ Birmingham, Canc Res UK Clin Trials Unit CRCTU, Birmingham, England
[3] Dana Farber Canc Inst, Boston, England
[4] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, England
[5] Cardiff Univ, Sch Med, Cardiff, Wales
[6] Clatterbridge Canc Hosp, Liverpool, England
[7] City Hosp Nottingham, Nottingham, England
[8] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England
[9] St James Hosp, Leeds, England
[10] Torbay Hosp, Torquay, England
[11] Countess Chester Hosp, Chester, England
[12] Manchester Royal Infirm, Dept Haematol, Manchester, England
[13] Milton Keynes Hosp NHS Fdn Trust, Milton Keynes, England
[14] Warwick Hosp, Warwick, England
[15] Kings Coll London, Dept Med & Mol Genet, London, England
[16] Guys & St Thomas Hosp, London, England
[17] Univ Hosp Coventry, Coventry, England
[18] Aberdeen Royal Infirm, Aberdeen, Scotland
[19] Queens Univ Belfast, Belfast, North Ireland
[20] Worcestershire Acute Hosp, Worcester, England
[21] Bradford Teaching Hosp, Bradford, England
[22] Kings Coll Hosp NHS Fdn Trust, Dept Haematol, London, England
[23] Royal Berkshire Hosp, Reading, England
[24] Royal Sussex Cty Hosp, Brighton, England
[25] Sandwell West Birmingham Hosp NHS Trust, WMRC, West Bromwich, England
[26] Beatson, Glasgow, Scotland
[27] Wirral Univ Teaching Hosp, Wirral, England
[28] Royal United Hosp Bath, Bath, England
[29] Univ Hosp Bristol & Weston NHS Trusts, Bristol, England
[30] Sheffield Univ Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, England
[31] Univ Sheffield, Florey Inst Host Pathogen Interact, Sheffield, England
[32] Royal Free Hosp, London, England
[33] UCL, London, England
[34] NHSBT, Oxford, England
[35] Oxford Univ Hosp, Oxford, England
[36] Univ Oxford, Oxford, England
关键词
D O I
10.1182/blood-2021-146061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1942
引用
收藏
页码:1942 / +
页数:6
相关论文
共 5 条
  • [1] First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study
    Wolach, Ofir
    Levi, Itai
    Canaani, Jonathan
    Tadmor, Tamar
    Tavor, Sigal
    Hellmann, Ilana
    Zuckerman, Tsila
    Lavie, David
    Stemer, Galia
    Cohen, Raanan
    Afik, Ran
    Ofek, Keren
    Banayan, Hilla
    Kan, Inna
    Grunspan, Moshe
    Ofran, Yishai
    Moshe, Yakir
    BLOOD, 2020, 136
  • [2] Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
    Budziszewska, Bozena Katarzyna
    Salomon-Perzynski, Aleksander
    Pruszczyk, Katarzyna
    Barankiewicz, Joanna
    Pluta, Agnieszka
    Helbig, Grzegorz
    Janowska, Anna
    Kuydowicz, Marta
    Bolkun, Lukasz
    Piszcz, Jaroslaw
    Patkowska, Elzbieta
    Watek, Marzena
    Malecki, Piotr
    Kosciolek-Zgodka, Sylwia
    Cichocka, Edyta
    Charlinski, Grzegorz
    Irga-Staniukiewicz, Anna
    Zaucha, Jan Maciej
    Piekarska, Agnieszka
    Gromek, Tomasz
    Hus, Marek
    Wojcik, Karol
    Razny, Malgorzata
    Sedzimirska, Mariola
    Pula, Bartosz
    Giebel, Sebastian
    Grosicki, Sebastian
    Wierzbowska, Agnieszka
    Lech-Maranda, Ewa
    CANCERS, 2021, 13 (16)
  • [3] Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
    Devine, Steven M.
    Owzar, Kouros
    Blum, William
    Mulkey, Flora
    Stone, Richard M.
    Hsu, Jack W.
    Champlin, Richard E.
    Chen, Yi-Bin
    Vij, Ravi
    Slack, James
    Soiffer, Robert J.
    Larson, Richard A.
    Shea, Thomas C.
    Hars, Vera
    Sibley, Alexander B.
    Giralt, Sergio
    Carter, Shelly
    Horowitz, Mary M.
    Linker, Charles
    Alyea, Edwin P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) : 4167 - +
  • [4] Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
    Scott, Bart L.
    Pasquini, Marcelo C.
    Logan, Brent
    Wu, Juan
    Devine, Steve
    Porter, David L.
    Maziarz, Richard T.
    Warlick, Erica
    Fernandez, Hugo F.
    Alyea, Edwin P.
    Hamadani, Mehdi
    Bashey, Asad
    Giralt, Sergio A.
    Leifer, Eric
    Geller, Nancy
    Le-Rademacher, Jennifer
    Mendizabal, Adam M.
    Horowitz, Mary M.
    Deeg, H. Joachim
    Horwitz, Mitchell E.
    BLOOD, 2015, 126 (23)
  • [5] Comparable results of HLA identical sibling donor peripheral blood hematopoietic stem cell transplantation after reduced-intensity and high-dose TBI-based CD34+-positive cell selection myeloablative preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission: Results from a prospective study.
    Martino, Rodrigo
    Valcarcel, David
    Pinana, Jose L.
    Sureda, Anna
    Brunet, Salut
    Briones, Javier
    Sanchez, Blanca
    Delgado, Julio
    Sierra, Jorge
    BLOOD, 2006, 108 (11) : 849A - 849A